Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells

por Bristol, Jillian A., Brand, Joshua, Ohashi, Makoto, Eichelberg, Mark R., Casco, Alejandro, Nelson, Scott E., Hayes, Mitchell, Romero-Masters, James C., Baiu, Dana C., Gumperz, Jenny E., Johannsen, Eric C., Dinh, Huy Q., Kenney, Shannon C.
Publicado 2022

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection

por Romero-Masters, James C., Huebner, Shane M., Ohashi, Makoto, Bristol, Jillian A., Benner, Bayleigh E., Barlow, Elizabeth A., Turk, Gail L., Nelson, Scott E., Baiu, Dana C., Van Sciver, Nicholas, Ranheim, Erik A., Gumperz, Jenny, Sherer, Nathan M., Farrell, Paul J., Johannsen, Eric C., Kenney, Shannon C.
Publicado 2020